Citalopram (Celexa) versus ...
- Citalopram vs Reboxetine
- Citalopram vs Fluoxetine
- Citalopram vs Escitalopram
- Citalopram vs Nortriptyline
- Citalopram vs Amitriptyline
- Citalopram vs Mirtazapine
Reboxetine may be more effective than citalopram in treating depression with high levels of fatigue 2.
|Results of double-blind study comparing reboxetine with citalopram in major depressive disorder 1.||Citalopram||Reboxetine|
|Regimen||20-40 mg per day during 24 weeks||8-10 mg per day during 24 weeks|
|Reduction of HAM-D scores||
greater reduction of the HAM-D scores
|Most common side effect||sexual dysfunction||dry mouth|
|Anorgasmia rate in sexually active women at week 24||
|Dropout, number of patients||
|Results of randomized double-blind comparison of citalopram versus reboxetine in outpatients with somatoform pain disorder. 3.||Citalopram||Reboxetine|
|Regimen||40 mg/day (N=17 patients)||8 mg/day (N=18 patients)|
|Present Pain Intensity (PPI) scores at baseline and after treatment||
3.5 vs. 2.8
3.7 vs. 3.1
|Total Pain Rating Index (tPRI) scores at baseline and after treatment||
41.9 vs. 30.0
35.2 vs. 31.5
|Results of single-blind, cross-over, flexible-dose pilot study of reboxetine and citalopram in panic disorder4.||Citalopram||Reboxetine|
|Response rate at week 18||9 of 11 patients (82%)||7 of 13 patients (54%)|
|1 non-responder to citalopram responded to reboxetine.
3 non-responders to reboxetine responded to citalopram.
|Results of randomized single-blind study of citalopram versus nortriptyline in late-life depression 5.||Citalopram||Nortriptyline|
|Number of drop-outs||
|Autonomic side-effects||citalopram is better tolerated||
significantly higher, particularly in endogenous or psychotic patients
|Results of comparison of citalopram versus amitriptyline in the treatment of major depression 6.||Citalopram||Amitriptyline|
|Percentage reduction on the Hamilton Depression Rating Scale||
|Percentage reduction at the end of the study on the CGI-Improvement Scale||
|Adverse effects rate||
|Results of comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients 8.||Citalopram||Amitriptyline|
|Regimen||20 or 40 mg/day||50 or 100 mg/day|
|Time-related declines in severity of depression||
by 8 weeks slightly more than 50% of the patients in each antidepressant group experienced marked recovery
|Dry mouth, rate||7%||34%|
|Somnolence, constipation, fatigue||more frequently|
Comorbidity of depression, migraine, and tension-type headache
Amitriptyline and citalopram are equally efficient in relieving depressive symptoms. However, amitriptyline appears to be more efficacious than citalopram in reducing migraine and tension-type headache attacks11.
Combined therapy with amitriptyline and citalopram may be particularly beneficial for individuals with tension-type headache, migraine and comorbid depression that do not respond to monotherapy.
Chronic tension-type headache
Amitriptyline can significantly reduce the duration of headache, headache frequency, and intake of analgesics, whereas citalopram has no significant useful effect 12.
Mirtazapine and citalopram are equally effective in reducing symptoms of depression and anxiety. However, mirtazapine was significantly more effective than citalopram after 2 weeks of treatment on the MADRS, HAM-A and CGI Severity of illness and Quality of life scales 10. Mirtazapine may provide faster improvement of sleep, quality of sleep and improved alertness following awakening.
|Results of a double-blind, randomized study of mirtazapine versus citalopram in patients with major depressive disorder10.||Citalopram||Mirtazapine|
|Mean MADRS scores after 8 weeks||9.1||8.9|
|Percentage of patients prematurely terminated the study||3%||3.6%|
|Most frequent side effects||sweating and nausea||increased appetite and complaints of weight increase|
- 1. Langworth S, Bodlund O, Agren H. Efficacy and tolerability of reboxetine compared with citalopram: a double-blind study in patients with major depressive disorder. J Clin Psychopharmacol. 2006 Apr;26(2):121-7. PubMed
- 2. Bould H, Wiles N, Potokar J, Cowen P, Nutt DJ, Peters TJ, Lewis G. Does baseline fatigue influence treatment response to reboxetine or citalopram in depression? An open label randomized controlled trial. J Psychopharmacol. 2012 May;26(5):663-9. PubMed
- 3. Aragona M, Bancheri L, Perinelli D, Tarsitani L, Pizzimenti A, Conte A, Inghilleri M. Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder. Eur J Pain. 2005 Feb;9(1):33-8. PubMed
- 4. Seedat S, van Rheede van Oudtshoorn E, Muller JE, Mohr N, Stein DJ. Reboxetine and citalopram in panic disorder: a single-blind, cross-over, flexible-dose pilot study. Int Clin Psychopharmacol. 2003 Sep;18(5):279-84. PubMed
- 5. Navarro V, Gasto' C, Torres X, Marcos T, Pintor L. Citalopram versus nortriptyline in late-life depression: a 12-week randomized single-blind study. Acta Psychiatr Scand. 2001 Jun;103(6):435-40. PubMed
- 6. Mathur A, Sharma DK, Choudhary A, Jain M. Efficacy and safety of citalopram versus amitriptyline in the treatment of major depression. Indian J Psychiatry. 2005 Apr;47(2):89-93. PubMed
- 7. Gravem A, Amthor KF, Astrup C, Elgen K, Gjessing LR, Gunby B, Pettersen RD, Kyrdalen L, Vaadal J, Ofsti E, et al. A double-blind comparison of citalopram (Lu 10-171) and amitriptyline in depressed patients. Acta Psychiatr Scand. 1987 May;75(5):478-86. PubMed
- 8. Kyle CJ, Petersen HE, Overø KF. Comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients treated in general practice. Depress Anxiety. 1998;8(4):147-53. PubMed
- 9. Rampello L, Alvano A, Chiechio S, Malaguarnera M, Raffaele R, Vecchio I, Nicoletti F. Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache. Neuropsychobiology. 2004;50(4):322-8. PubMed
- 10. Leinonen E, Skarstein J, Behnke K, Agren H, Helsdingen JT. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Int Clin Psychopharmacol. 1999 Nov;14(6):329-37. PubMed
- 11. Rampello L, Alvano A, Chiechio S, Malaguarnera M, Raffaele R, Vecchio I, Nicoletti F. Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache. Neuropsychobiology. 2004;50(4):322-8. PubMed
- 12. Bendtsen L, Jensen R, Olesen J. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry. 1996 Sep;61(3):285-90. PubMed
- 14. Rosenberg C, Lauritzen L, Brix J, Jørgensen JB, Kofod P, Bayer LB. Citalopram versus amitriptyline in elderly depressed patients with or without mild cognitive dysfunction: a danish multicentre trial in general practice. Psychopharmacol Bull. 2007;40(1):63-73.
Published: March 31, 2008
Last updated: February 18, 2017